Explore trusted hospitals and care options, or get personalised support to find a suitable option based on your treatment needs, preferences, and budget.
Sheba Medical Center offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 1948, the JCI accredited hospital is situated in Ramat Gan, Israel, with 1900 beds, serving local and international patients.
Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.
With advanced hepatobiliary oncology infrastructure, Herzliya Medical Center offers Cholangiocarcinoma Treatment for patients requiring specialised care for bile duct cancer. Established in 1983, the accredited hospital is located in Herzliya, Israel, and has 120 beds.
For selected patients with resectable disease, surgery may involve removal of the affected bile duct, part of the liver, or other nearby tissues, depending on tumour location. Advanced disease may require systemic treatment or palliative procedures such as biliary stenting. A multidisciplinary team evaluates imaging, pathology, tumour stage, and overall health before recommending treatment.
With advanced hepatobiliary oncology infrastructure, American Oncology Institute offers Cholangiocarcinoma Treatment for patients requiring specialised care for bile duct cancer. Established in 2013, the NABH accredited hospital is located in Hyderabad, India, and has 150 beds.
For selected patients with resectable disease, surgery may involve removal of the affected bile duct, part of the liver, or other nearby tissues, depending on tumour location. Advanced disease may require systemic treatment or palliative procedures such as biliary stenting. A multidisciplinary team evaluates imaging, pathology, tumour stage, and overall health before recommending treatment.
Istanbul, Turkey
Acibadem University Hospital Atakent provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2014, the JCI accredited hospital is based in Istanbul, Turkey, with 278 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
At Iranian Hospital, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 1970, the accredited hospital is located in Dubai, United Arab Emirates, and has 220 beds.
Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.
Istanbul, Turkey
Istinye University Bahcesehir - LIV Hospital offers advanced Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern oncology and hepatobiliary surgery techniques and internationally accepted treatment protocols. Established in 2016, the ISO, JCI accredited hospital is located in Istanbul, Turkey, with 394 beds, providing comprehensive cancer care for local and international patients.
Treatment depends on the location, stage, and extent of the bile duct cancer. Surgery may be considered for tumours that can be completely removed, while advanced disease may require chemotherapy, targeted therapy, immunotherapy, or radiation therapy. Detailed imaging, tissue diagnosis, and molecular testing may help specialists determine the most appropriate treatment approach.
KCM Clinic offers advanced Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern oncology and hepatobiliary surgery techniques and internationally accepted treatment protocols. Established in 2006, the ISO accredited hospital is located in Jelenia Gora, Poland, with 85 beds, providing comprehensive cancer care for local and international patients.
Treatment depends on the location, stage, and extent of the bile duct cancer. Surgery may be considered for tumours that can be completely removed, while advanced disease may require chemotherapy, targeted therapy, immunotherapy, or radiation therapy. Detailed imaging, tissue diagnosis, and molecular testing may help specialists determine the most appropriate treatment approach.
VM Medical Park Bursa Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2017, the JCI accredited hospital is based in Bursa, Turkey, with 270 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
Life Kingsbury Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1918, the accredited hospital is based in Cape Town, South Africa, with 212 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
Medical Park Goztepe Hospital offers advanced Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern oncology and hepatobiliary surgery techniques and internationally accepted treatment protocols. Established in 2005, the JCI accredited hospital is located in Istanbul, Turkey, with 293 beds, providing comprehensive cancer care for local and international patients.
Treatment depends on the location, stage, and extent of the bile duct cancer. Surgery may be considered for tumours that can be completely removed, while advanced disease may require chemotherapy, targeted therapy, immunotherapy, or radiation therapy. Detailed imaging, tissue diagnosis, and molecular testing may help specialists determine the most appropriate treatment approach.
Mumbai, India
With advanced hepatobiliary oncology infrastructure, Bai Jerbai Wadia Hospital for Children offers Cholangiocarcinoma Treatment for patients requiring specialised care for bile duct cancer. Established in 1929, the AACI accredited hospital is located in Mumbai, India, and has 350 beds.
For selected patients with resectable disease, surgery may involve removal of the affected bile duct, part of the liver, or other nearby tissues, depending on tumour location. Advanced disease may require systemic treatment or palliative procedures such as biliary stenting. A multidisciplinary team evaluates imaging, pathology, tumour stage, and overall health before recommending treatment.
At Riyadh Care Hospital, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 1990, the JCI accredited hospital is located in Riyadh, Saudi Arabia, and has 325 beds.
Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.
With advanced hepatobiliary oncology infrastructure, Care national Hospital offers Cholangiocarcinoma Treatment for patients requiring specialised care for bile duct cancer. Established in 2003, the JCI accredited hospital is located in Riyadh, Saudi Arabia, and has 460 beds.
For selected patients with resectable disease, surgery may involve removal of the affected bile duct, part of the liver, or other nearby tissues, depending on tumour location. Advanced disease may require systemic treatment or palliative procedures such as biliary stenting. A multidisciplinary team evaluates imaging, pathology, tumour stage, and overall health before recommending treatment.
Hospital Ruber International offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 1982, the ISO accredited hospital is situated in Madrid, Spain, with 345 beds, serving local and international patients.
Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.
Paracelsus Clinic provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1953, the accredited hospital is based in Lustmuhle, Switzerland, with 95 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.